Prestige Consumer Healthcare Total Liabilities 2010-2025 | PBH

Prestige Consumer Healthcare total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
Prestige Consumer Healthcare Annual Total Liabilities
(Millions of US $)
2025 $1,567
2024 $1,663
2023 $1,907
2022 $2,093
2021 $2,071
2020 $2,343
2019 $2,345
2018 $2,582
2017 $3,089
2016 $2,204
2015 $2,014
2014 $1,232
2013 $1,262
2012 $1,356
2011 $695
2010 $462
2009 $507
Prestige Consumer Healthcare Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $1,567
2024-12-31 $1,541
2024-09-30 $1,585
2024-06-30 $1,627
2024-03-31 $1,663
2023-12-31 $1,739
2023-09-30 $1,797
2023-06-30 $1,865
2023-03-31 $1,907
2022-12-31 $2,063
2022-09-30 $2,059
2022-06-30 $2,097
2022-03-31 $2,093
2021-12-31 $2,141
2021-09-30 $2,214
2021-06-30 $2,143
2021-03-31 $2,071
2020-12-31 $2,146
2020-09-30 $2,156
2020-06-30 $2,223
2020-03-31 $2,343
2019-12-31 $2,308
2019-09-30 $2,352
2019-06-30 $2,359
2019-03-31 $2,345
2018-12-31 $2,435
2018-09-30 $2,504
2018-06-30 $2,607
2018-03-31 $2,582
2017-12-31 $2,680
2017-09-30 $3,006
2017-06-30 $3,041
2017-03-31 $3,089
2016-12-31 $2,011
2016-09-30 $2,056
2016-06-30 $2,141
2016-03-31 $2,204
2015-12-31 $1,920
2015-09-30 $1,941
2015-06-30 $1,974
2015-03-31 $2,014
2014-12-31 $2,072
2014-09-30 $2,132
2014-06-30 $1,268
2014-03-31 $1,232
2013-12-31 $1,321
2013-09-30 $1,267
2013-06-30 $1,236
2013-03-31 $1,262
2012-12-31 $1,274
2012-09-30 $1,349
2012-06-30 $1,334
2012-03-31 $1,356
2011-12-31 $644
2011-09-30 $664
2011-06-30 $671
2011-03-31 $695
2010-12-31 $699
2010-09-30 $440
2010-06-30 $436
2010-03-31 $462
2009-12-31 $462
2009-09-30 $486
2009-06-30 $494
2009-03-31 $507
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.897B $1.138B
Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $152.324B 38.13
Stryker (SYK) United States $149.641B 31.29
EssilorLuxottica (ESLOY) France $137.721B 0.00
Medtronic (MDT) Ireland $114.146B 16.18
Lonza Group Ag (LZAGY) Switzerland $51.237B 0.00
Haleon (HLN) United Kingdom $45.147B 25.77
ResMed (RMD) United States $37.534B 28.19
GE HealthCare Technologies (GEHC) United States $34.575B 16.42
Agilent Technologies (A) United States $34.457B 22.46
Terumo (TRUMY) Japan $25.051B 32.54
Koninklijke Philips (PHG) Netherlands $23.235B 16.30
Insulet (PODD) United States $20.934B 82.17
Zimmer Biomet Holdings (ZBH) United States $18.835B 12.10
Baxter (BAX) United States $15.298B 11.42
Smith & Nephew SNATS (SNN) United Kingdom $13.441B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.887B 23.97
Lantheus Holdings (LNTH) United States $5.776B 14.57
Perrigo (PRGO) Ireland $3.742B 9.48
Haemonetics (HAE) United States $3.724B 16.96
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.454B 28.70
ICU Medical (ICUI) United States $3.341B 24.63
QuidelOrtho (QDEL) United States $2.135B 14.68
LeMaitre Vascular (LMAT) United States $1.910B 42.70
AtriCure (ATRC) United States $1.580B 0.00
Acuren (TIC) United States $1.397B 0.00
Phibro Animal Health (PAHC) United States $1.272B 16.26
Green Thumb Industries (GTBIF) United States $1.249B 28.09
AdaptHealth (AHCO) United States $1.247B 12.66
Neogen (NEOG) United States $1.194B 15.28
BioLife Solutions (BLFS) United States $1.068B 0.00
InMode (INMD) Israel $0.963B 9.70
Kestra Medical Technologies (KMTS) United States $0.791B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.703B 0.00
Tilray Brands (TLRY) Canada $0.679B 0.00
Curaleaf Holdings (CURLF) Canada $0.670B 0.00
Owens & Minor (OMI) United States $0.667B 5.53
Evolus (EOLS) United States $0.623B 0.00
CeriBell (CBLL) United States $0.596B 0.00
Capricor Therapeutics (CAPR) United States $0.522B 0.00
Valneva SE (VALN) France $0.502B 0.00
Surmodics (SRDX) United States $0.441B 0.00
SNDL (SNDL) Canada $0.373B 0.00
VAREX IMAGING (VREX) United States $0.347B 12.77
Sanuwave Health (SNWV) United States $0.308B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Quanterix (QTRX) United States $0.295B 0.00
Cresco Labs (CRLBF) United States $0.291B 0.00
Cerus (CERS) United States $0.285B 0.00
Viemed Healthcare (VMD) United States $0.276B 23.27
Sanara MedTech (SMTI) United States $0.269B 0.00
ZimVie (ZIMV) United States $0.264B 12.01
Brainsway (BWAY) Israel $0.246B 65.00
Canopy Growth (CGC) Canada $0.232B 0.00
OraSure Technologies (OSUR) United States $0.227B 0.00
Biote (BTMD) United States $0.225B 6.34
Verano Holdings (VRNOF) United States $0.210B 0.00
Omeros (OMER) United States $0.198B 0.00
Organigram Global (OGI) Canada $0.193B 0.00
High Tide (HITI) Canada $0.190B 0.00
TriSalus Life Sciences (TLSI) United States $0.190B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.15
Vireo Growth (VREOF) United States $0.150B 0.00
Exagen (XGN) United States $0.145B 0.00
FitLife Brands (FTLF) United States $0.126B 15.53
TerrAscend (TSNDF) Canada $0.104B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Fonar (FONR) United States $0.096B 12.37
Jin Medical (ZJYL) China $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Apyx Medical (APYX) United States $0.086B 0.00
Quipt Home Medical (QIPT) United States $0.082B 0.00
Veru (VERU) United States $0.081B 0.00
Jushi Holdings (JUSHF) United States $0.072B 0.00
Zynex (ZYXI) United States $0.072B 0.00
InterCure (INCR) Israel $0.072B 0.00
Agape ATP (ATPC) $0.071B 0.00
Cytosorbents (CTSO) United States $0.070B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
Rockwell Medical (RMTI) United States $0.041B 0.00
Nephros (NEPH) United States $0.040B 53.29
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.037B 12.82
Safety Shot (SHOT) United States $0.033B 0.00
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.016B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00